This site is intended for health professionals only
Thursday 26 April 2018
Share |

HHE Extra

Non-compliant and counterfeit medical devices

Tuesday 17th April 2018

While sitting on the beach in some sunny clime we have probably all no doubt witnessed the annoying presence of the “knock off” watch, phone charger or handbag salesmen. While they may be irritating, we probably give little thought to the impact that these individuals are having on the original brands. Indeed, you might even make a purchase, accepting the fact that the product may not last long or operate correctly.

However, when back at the day job, it...

Wed, 11 Apr 2018
Karl Landsteiner University of Health Sciences computes the smartest distribution of emergency medical service stations
Mon, 9 Apr 2018
New centres being set up across the country mark a "step change" in cancer care NHS England said
Fri, 6 Apr 2018
Eight health and care organisations and four suppliers used tools from Integrating the Healthcare Enterprise, NHS Digital and Endeavor Health to test information sharing at an event that helped Orion Health to win the contract for the Dorset Care Record. Neil Robinson, chair of IHE UK, argues this could be a model for future tenders.
Wed, 28 Mar 2018
The merger by acquisition of Birmingham’s two largest hospital trusts is to go ahead on 1 April 2018
Mon, 26 Mar 2018
Achieving optimum patient flow is at the very top of the healthcare agenda – indeed it is a barometer for the health of the NHS itself. James Ferris, Account Manager for Aptean Medworxx, explains the advantages of adopting a software-based solution to deliver the evidence-based benefits prescribed by NHS Clinical Utilisation Review (CUR) policy
Sat, 10 Mar 2018
By early 2019, clinicians across the North of Scotland will have access to an integrated digital view of a patient’s health and social care data through a new web-based portal provided by Orion Health
Mon, 26 Feb 2018
A preventative treatment for peanut allergies, one of the most severe food allergies, has been developed by San Francisco-based Aimmune Therapeutics and could be the world’s first approved drug for this condition